Back to search

Article

Peptide-MHC-targeted retroviruses enable <i>in vivo</i> expansion and gene delivery to tumor-specific T cells

2024-09-22

Abstract excerpt

Tumor-infiltrating-lymphocyte (TIL) therapy has demonstrated that endogenous T cells can be harnessed to initiate an effective anti-tumor response. Despite clinical promise, current TIL production protocols involve weeks-long ex vivo expansions which can affect treatment efficacy. Therefore, additional tools are needed to engineer endogenous tumor-specific T cells to have increased potency while mitigating challe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3dcae8bc-1824-5039-8ac1-3be73ee6ba5d
DOI
10.1101/2024.09.18.613594
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Peptide-MHC-targeted retroviruses enable <i>in vivo</i> expansion and gene delivery to tumor-specific T cellsDOI 10.1101/2024.09.18.613594
Select a neighboring publication to make it the new centre.